Abdallah M. Ibrahim: Evolving Hemophilia Care – How Do We Choose the Right Biomarkers?
Abdallah M. Ibrahim, Senior Medical Student at Alexandria University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in ASIDE, adding:
“Glad to share another research publication that our narrative review, ‘Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility,’ has been published in American Society for Inclusion, Diversity, and Equity in Healthcare (ASIDE) Internal medicine (Vol. 2, No. 5, 2026).
Hemophilia care is evolving fast:
Extended half-life therapies, non-factor treatments, and gene therapy are changing what’s possible, but that progress raises a real question: how do we select the right biomarkers to guide diagnosis, risk stratification, and treatment choice?
Our review synthesized the literature from 2000 to 2025, covering established tools (FVIII/FIX activity assays, inhibitor testing, genotyping, imaging-based joint assessment) alongside emerging candidates like global hemostasis assays and inflammatory biomarkers linked to joint disease.
The conclusion is honest: evidence in this space is still heterogeneous, and most non-traditional markers remain exploratory pending standardized, multicenter validation.”
Title: Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility: A Narrative Review of the Literature
Authors: Dalia Atef Abouda, Elsayed S. Moubarak, Fatma ElBadrawy, Malak A. Hassan, Mohamed Mohsen Helal, Abdallah M. Ibrahim, Hassan H. Eladl, Mohammad Mahadin, Mohamed Elsaid
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 29, 2026, 17:05What If Factor XI inhibition Could Reshape the Future of Anticoagulation – ISTH
-
Aug 29, 2026, 16:44Nipocalimab for Warm Autoimmune Hemolytic Anemia: What the FDA Approval Means
-
Aug 29, 2026, 16:17The Future of Bleeding Disorder Research is Getting Bigger – Global Hemophilia Report
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 16:00Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community